Gene therapy for ocular hypertension using hfCas13d-mediated mRNA targeting is a research paper published in PNAS Nexus (2025). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01EY032159-01
Phosphoinositide signaling in glaucoma: rescue strategies for Lowe syndrome
National Institutes of Health
Grant: 5K12EY033745-02
Stanford K12 Clinician-Scientist Career Development Program
National Institutes of Health
Grant: 1R38EY037090-01
Stanford Ophthalmology Advanced Research Program
National Institutes of Health
Grant: 1I01BX005831-01
Diabetic Complications and Genetic Variants in the Million Veterans Program
National Institutes of Health
Grant: 1K99EY034932-01
Primary Cilia of Astrocytes in Glaucoma
National Institutes of Health
Grant: 5R01EY025295-05
The role of primary cilia in glaucoma pathogenesis
National Institutes of Health
Grant: 5I01CX001481-04
Shedding light on glaucoma: optogenetics regulation of ciliary phosphoinositides
Children's Health Research Institute
International Retinal Research Foundation
NIH
FWCI
3.08
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords